«We believe that our results and methodology could further improve
vaccine strain selection process and, thereby, enhance vaccine efficacy.
While this year's vaccine is a much better match to the circulating seasonal strains of influenza, the shifty nature of the virus and the need to pick the viruses used to make global vaccine stocks well before the onset of the flu season can make
vaccine strain selection a shot in the dark.
Not exact matches
Such GOF studies are «crucial» for the
selection of each year's candidate
vaccine viruses because they help WHO identify the riskiest
strains in the wild, Schultz - Cherry said.
Most of the time, the
vaccine's lackluster performance is blamed on poor
strain selection.